Annika A. Lindblom

Annika A. Lindblom's AcademicInfluence.com Rankings

Annika A. Lindblom

Biology

#12939

World Rank

#16447

Historical Rank

Genetics

#1421

World Rank

#1523

Historical Rank

biology Degrees

Download Badge

Biology

Annika A. Lindblom's Degrees

PhD Genetics University of Helsinki

Why Is Annika A. Lindblom Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Annika A. Lindblom's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. (2004) (2947)
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer (1994) (2147)
Corrigendum: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (2009) (1432)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
Association analysis identifies 65 new breast cancer risk loci (2017) (922)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial (2011) (826)
Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer (2007) (787)
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts (2013) (656)
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types (2009) (613)
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. (2008) (516)
Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer (2008) (490)
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
Genetic mapping of a second locus predisposing to hereditary non–polyposis colon cancer (1993) (450)
Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
Sequence variant on 8q24 confers susceptibility to urinary bladder cancer (2008) (410)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database (2015) (389)
RAD51B in Familial Breast Cancer (2016) (366)
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database (2017) (365)
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing (2004) (349)
ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma (2008) (335)
Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
New common variants affecting susceptibility to basal cell carcinoma (2009) (321)
Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2019) (280)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (279)
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility (2011) (261)
Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer (2001) (258)
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer (2009) (253)
Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. (2008) (246)
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk (2012) (234)
Different mechanisms in the tumorigenesis of proximal and distal colon cancers (2001) (227)
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
Lynch syndrome (hereditary nonpolyposis colorectal cancer) diagnostics. (2007) (224)
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) (205)
Molecular basis of HNPCC: Mutations of MMR genes (1997) (201)
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
Tumor-associated zinc finger mutations in the CTCF transcription factor selectively alter tts DNA-binding specificity. (2002) (186)
Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. (2015) (178)
Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. (2001) (176)
Mechanism of diarrhea in collagenous colitis. (2001) (174)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer (2010) (174)
Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. (2008) (172)
CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. (2012) (164)
Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status. (2004) (154)
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers (1998) (153)
Colorectal cancer with and without microsatellite instability involves different genes (1999) (149)
Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial (2020) (141)
Identification of susceptibility loci for colorectal cancer in a genome-wide meta-analysis. (2014) (139)
ATM mutations in cancer families. (1996) (135)
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer. (2001) (135)
Mutation screening in the hMLH1 gene in Swedish hereditary nonpolyposis colon cancer families. (1995) (134)
European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. (2011) (133)
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals (2012) (133)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. (2012) (129)
Cancer Risks for PMS2-Associated Lynch Syndrome. (2018) (128)
A rare CYP19 (aromatase) variant may increase the risk of breast cancer. (1998) (124)
The role of ataxia-telangiectasia heterozygotes in familial breast cancer. (1998) (123)
Identification of nine new susceptibility loci for endometrial cancer (2018) (122)
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
Recommendations to improve identification of hereditary and familial colorectal cancer in Europe (2010) (121)
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database (2016) (120)
Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer (2002) (120)
High allele loss rates at I7q I2‐q2I in breast and ovarian tumors from BRCAI‐linked families (1995) (118)
Hyperplastic polyposis coli syndrome and colorectal carcinoma. (2006) (118)
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
Microsatellite Instability and hMLH1 and hMSH2 Expression Analysis in Familial and Sporadic Colorectal Cancer (2001) (114)
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus (2010) (113)
Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
Altered expression of MLH1, MSH2, and MSH6 in predisposition to hereditary nonpolyposis colorectal cancer. (2003) (108)
The role of hMLH3 in familial colorectal cancer. (2003) (107)
Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC) – Results of an international collaborative study (2001) (105)
Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor (1999) (105)
Microsatellite instability as a predictor of a mutation in a DNA mismatch repair gene in familial colorectal cancer (2000) (104)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
Novel Common Genetic Susceptibility Loci for Colorectal Cancer (2018) (102)
MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. (2001) (101)
Differential expression of Aquaporin 8 in human colonic epithelial cells and colorectal tumors (2001) (97)
Association of ESR1 gene tagging SNPs with breast cancer risk. (2009) (95)
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk (2012) (94)
Long‐range PCR facilitates the identification of PMS2‐specific mutations (2006) (93)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression (1994) (91)
Obesity, Aspirin, and Risk of Colorectal Cancer in Carriers of Hereditary Colorectal Cancer: A Prospective Investigation in the CAPP2 Study. (2015) (91)
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters. (1998) (89)
Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study (2002) (88)
CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk (2002) (87)
Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer (1997) (86)
Tumour markers in malignancies (2000) (84)
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (82)
Evaluation of Psychosocial Effects of Pre-Symptomatic Testing for Breast/Ovarian and Colon Cancer Pre-Disposing Genes: A 12-Month Follow-Up (2004) (82)
Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps (2003) (82)
Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. (1993) (81)
Ki-ras mutations and prognosis in colorectal cancer. (1998) (79)
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. (2019) (78)
BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis (2020) (76)
Fine scale mapping of the breast cancer 16q12 locus. (2010) (76)
Combined genetic and splicing analysis of BRCA1 c.[594-2A>C; 641A>G] highlights the relevance of naturally occurring in-frame transcripts for developing disease gene variant classification algorithms. (2016) (75)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. (2020) (74)
Missense mutations in hMLH1 associated with colorectal cancer (1999) (73)
Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? (2004) (71)
Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
Genetic modifiers of CHEK2*1100delC associated breast cancer risk (2016) (68)
Shared heritability and functional enrichment across six solid cancers (2018) (67)
BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
Common variants in human CRC genes as low-risk alleles. (2010) (67)
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses (2019) (66)
Microsatellite instability and mismatch repair gene inactivation in sporadic pancreatic and colon tumours (1999) (65)
Five endometrial cancer risk loci identified through genome-wide association analysis (2016) (64)
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility (2011) (64)
Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32–31.1 (2005) (61)
Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer (2005) (60)
Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
Hereditary breast cancer: a review. (2000) (60)
Polymorphism in the promoter region of the NFKB1 gene increases the risk of sporadic colorectal cancer in Swedish but not in Chinese populations (2007) (60)
Various mutation screening techniques in the DNA mismatch repair genes hMSH2 and hMLH1. (1999) (59)
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
Loss of heterozygosity in familial breast carcinomas. (1993) (58)
Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. (1994) (57)
Family history of colorectal cancer in a Sweden county (2004) (57)
Clinicopathological analysis of colorectal cancer: a comparison between emergency and elective surgical cases (2013) (57)
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. (1995) (56)
A human compound heterozygote for two MLH1 missense mutations (1997) (56)
Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses (2018) (56)
The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (55)
Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer (2016) (54)
Screening for genomic rearrangements of the MMR genes must be included in the routine diagnosis of HNPCC (2004) (53)
A frame-shift mutation of PMS2 is a widespread cause of Lynch syndrome (2008) (53)
COL11A1 in FAP polyps and in sporadic colorectal tumors (2001) (52)
Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer (2015) (50)
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer (2009) (50)
Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study (2020) (49)
Frequent alterations of the PI3K/AKT/mTOR pathways in hereditary nonpolyposis colorectal cancer (2010) (49)
Mutation analyses of KRAS exon 1 comparing three different techniques: temporal temperature gradient electrophoresis, constant denaturant capillary electrophoresis and allele specific polymerase chain reaction. (1998) (48)
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk (2014) (47)
A germline E-cadherin mutation in a family with gastric and colon cancer. (2001) (47)
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
Low frequency of E-cadherin alterations in familial breast cancer (2001) (46)
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report (2017) (46)
High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer (2005) (46)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
A study of the PTEN/MMAC1 gene in 136 breast cancer families. (1998) (46)
Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer (2005) (45)
Family History, and Impact on Clinical Presentation and Prognosis, in a Population-based Breast Cancer Cohort from the Stockholm County (2006) (45)
Somatic BRAF-V600E Mutations in Familial Colorectal Cancer (2006) (45)
Germline mutations in the MYH gene in Swedish familial and sporadic colorectal cancer. (2005) (44)
Analysis of colorectal cancer morphology in relation to sex, age, location, and family history (2012) (44)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
A genome-wide scan suggests a susceptibility locus on 5p13 for nasopharyngeal carcinoma (2008) (43)
The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome (2012) (42)
A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. (1997) (42)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
Prevalence of adenomas and hyperplastic polyps in mismatch repair mutation carriers among CAPP2 participants: report by the colorectal adenoma/carcinoma prevention programme 2. (2008) (41)
Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. (2014) (41)
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q (2008) (40)
Preoperative psychological reactions and quality of life among women with an increased risk of breast cancer who are considering a prophylactic mastectomy. (2004) (40)
Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population. (2016) (39)
Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) (38)
How to catch all those mutations—the report of the Third Human Variome Project Meeting, UNESCO Paris, May 2010 (2010) (38)
Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
Classification of colorectal polyps: guidelines for the endoscopist. (2002) (38)
Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
Definition of candidate low risk APC alleles in a Swedish population (2004) (36)
Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (35)
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
Germline BRCA1 and HMLH1 mutations in a family with male and female breast carcinoma (2000) (35)
The 5′ region of the MSH2 gene involved in hereditary non‐polyposis colorectal cancer contains a high density of recombinogenic sequences (2005) (35)
Lack of an Association between the TGFBR1*6A Variant and Colorectal Cancer Risk (2007) (34)
Individuals with an increased risk of colorectal cancer: perceived benefits and psychological aspects of surveillance by means of regular colonoscopies. (2004) (34)
Germline mutation screening of the STK11/LKB1 gene in familial breast cancer with LOH on 19p (2000) (34)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (34)
No mutations in the BACH1 gene in BRCA1 and BRCA2 negative breast‐cancer families linked to 17q22 (2002) (33)
Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD) (2007) (33)
DGGE screening of mutations in mismatch repair genes (hMSH2 and hMLH1) in 34 Swedish families with colorectal cancer (1998) (33)
Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors. (2003) (33)
BRCA1 mutations in a population-based study of breast cancer in Stockholm County. (2004) (33)
Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. (2019) (33)
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report (2019) (33)
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1 (2015) (32)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer (2015) (32)
Risk perception after genetic counseling in patients with increased risk of cancer (2009) (31)
The added value of PMS2 immunostaining in the diagnosis of hereditary nonpolyposis colorectal cancer (2006) (31)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
Linkage to chromosome 2q32.2-q33.3 in familial serrated neoplasia (Jass syndrome) (2010) (30)
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours (2009) (29)
Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (2019) (28)
Low frequency of hMSH2 mutations in Swedish HNPCC families (1997) (27)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) (27)
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
The APC gene I1307K variant is rare in Norwegian patients with familial and sporadic colorectal or breast cancer. (1998) (27)
Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
Bioinformatics for Human Genetics: Promises and Challenges (2011) (26)
Circulating bilirubin levels and risk of colorectal cancer: serological and Mendelian randomization analyses (2020) (26)
Exome sequencing in one family with gastric- and rectal cancer (2016) (26)
APC I1307K and E1317Q variants are rare or do not occur in Swedish colorectal cancer patients. (2001) (26)
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer (2016) (25)
Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer (2020) (25)
Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk (2015) (25)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2017) (25)
Identifying novel susceptibility genes for colorectal cancer risk from a transcriptome-wide association study of 125,478 subjects. (2020) (24)
Screening for TP53 mutations in patients and tumours from 109 Swedish breast cancer families. (1997) (24)
Loss of heterozygosity at chromosome 3p correlates with telomerase activity in renal cell carcinoma. (1998) (24)
Meta-Analysis of Mismatch Repair Polymorphisms within the Cogent Consortium for Colorectal Cancer Susceptibility (2013) (24)
9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium (2012) (24)
A pooled analysis of the outcome of prospective colonoscopic surveillance for familial colorectal cancer (2014) (24)
MSH2 codon 322 Gly to Asp seems not to confer an increased risk for colorectal cancer susceptibility. (1998) (24)
BRCA2 germline mutations in Swedish breast cancer families (1998) (23)
Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. (2015) (23)
Mendelian randomization analysis of C-reactive protein on colorectal cancer risk. (2018) (23)
Association of ESR 1 gene tagging SNPs with breast cancer risk (2009) (23)
A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (22)
Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report (2019) (22)
Genetic architectures of proximal and distal colorectal cancer are partly distinct (2020) (21)
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (20)
The gynecological surveillance of women with Lynch syndrome in Sweden. (2015) (20)
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (20)
2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy (2014) (19)
CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12. (2005) (19)
Familial breast cancer, underlying genes, and clinical implications: a review. (2006) (19)
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and Colorectal Cancer Risk (2020) (18)
DNA mismatch repair gene hMLH3 variants in meiotic arrest. (2007) (18)
BRCA 1 R 1699 Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk (2012) (18)
The CHEK2 1100delC variant in Swedish colorectal cancer. (2006) (18)
Colorectal cancer susceptibility loci in a population-based study: Associations with morphological parameters. (2010) (18)
The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
Linkage analysis with markers on 17q in 29 Swedish breast cancer families. (1993) (18)
Systematic meta-analyses, field synopsis and global assessment of the evidence of genetic association studies in colorectal cancer (2019) (16)
Deciphering the colon cancer genes—report of the InSiGHT‐Human Variome Project Workshop, UNESCO, Paris 2010 (2011) (16)
A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility. (2003) (16)
Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
Regular review: tumour markers in malignancies. (2000) (16)
TGFBR1 variants TGFBR1*6A and Int7G24A are not associated with an increased familial colorectal cancer risk (2009) (16)
The BRCA1 exon 13 duplication in the Swedish population (2004) (15)
The Role of hMLH 3 in Familial Colorectal Cancer 1 (2003) (15)
A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer (2007) (15)
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients (2015) (15)
Evidence that the 5 p 12 Variant rs 10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF 10 and MRPS 30 Regulation (15)
First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. (2001) (15)
A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer (2004) (15)
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2019) (15)
Mutation analysis of the DBC2 gene in sporadic and familial breast cancer (2007) (15)
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus (2016) (14)
Breast Cancer Risk Factors and Survival by Tumor Subtype: Pooled Analyses from the Breast Cancer Association Consortium (2021) (14)
Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (2012) (14)
The effect of genotypes and parent of origin on cancer risk and age of cancer development in PMS2 mutation carriers (2015) (14)
Finnish mutations in Swedish HNPCC families (1995) (14)
Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
Genetic rearrangements in sporadic and familial gastric carcinomas detected with microsatellite markers. (1994) (14)
Exome sequencing in 51 early onset non‐familial CRC cases (2019) (13)
Genetic anticipation in Swedish Lynch syndrome families (2017) (13)
Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer (2018) (13)
The metastatic phenotype--prognostic implications. (1996) (13)
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden (2015) (12)
Prediction of contralateral breast cancer: external validation of risk calculators in 20 international cohorts (2020) (12)
CHEK2 1100delC is prevalent in Swedish early onset familial breast cancer (2007) (12)
Cyclin D2 expression in familial and sporadic breast cancer. (2002) (12)
A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families (2007) (12)
BRCA1 screening in patients with a family history of breast or ovarian cancer. (1999) (11)
Sublocalization of a locus at 3p21.3–23 predisposing to hereditary nonpolyposis colon cancer (1994) (11)
Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk (2014) (11)
No Difference in Penetrance between Truncating and Missense/Aberrant Splicing Pathogenic Variants in MLH1 and MSH2: A Prospective Lynch Syndrome Database Study (2021) (11)
Four separate regions on chromosome 17 show loss of heterozygosity in familial breast carcinomas (1993) (11)
Colorectal cancer as a complex disease: defining at-risk subjects in the general population – a preventive strategy (2004) (11)
Identification of Novel Loci and New Risk Variant in Known Loci for Colorectal Cancer Risk in East Asians (2019) (10)
Missense mutations in hMLH1 associated with colorectal cancer. (1999) (10)
Linkage Analysis in Familial Non-Lynch Syndrome Colorectal Cancer Families from Sweden (2013) (10)
Missense mutations in hMLH 1 associated with colorectal cancer (10)
The biology of inherited cancer. (2000) (10)
Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study. (2021) (10)
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) (10)
Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up (2022) (10)
The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer: Genetic Association Study in 18,723 Individuals (2014) (9)
No evidence for a familial breast cancer susceptibility gene at chromosome 13q21 in Swedish breast cancer families (2002) (9)
Screening of 229 family cancer patients for a germline estrogen receptor gene (ESR) base mutation (1997) (9)
Long‐range PCR facilitates the identification of PMS2‐specific mutations (2006) (9)
A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families (2018) (9)
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance (2019) (9)
Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1 (2017) (9)
Histological changes pertinent to local tumor progression in hereditary nonpolyposis colorectal cancer (HNPCC). A preliminary report. (2004) (9)
A Combined Proteomics and Mendelian Randomization Approach to Investigate the Effects of Aspirin-Targeted Proteins on Colorectal Cancer (2020) (8)
Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2022) (8)
Hereditary breast cancer in sweden: a predominance of maternally inherited cases (2005) (8)
Genome-wide association study yields variants at 20 p 12 . 2 that associate with urinary bladder cancer (2014) (7)
Predicting Outcome in Colonoscopic High-risk Surveillance. (2015) (7)
Defining New Colorectal Cancer Syndromes in a Population-based Cohort of the Disease. (2017) (7)
Colorectal cancer incidences in Lynch syndrome: a comparison of results from the prospective lynch syndrome database and the international mismatch repair consortium (2022) (7)
Familial cancer among consecutive uterine cancer patients in Sweden (2014) (7)
Re: Dominant negative ATM mutations in breast cancer families. (2002) (7)
Cancer risk susceptibility loci in a Swedish population (2017) (7)
Familial breast cancer and genes involved in breast carcinogenesis (1995) (7)
Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome (2018) (7)
Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population (2018) (6)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
Variants of the PPARD Gene and Their Clinicopathological Significance in Colorectal Cancer (2013) (6)
The inframe MSH2 codon 596 deletion is linked with HNPCC and associated with lack of MSH2 protein in tumours (2004) (6)
The Role of hPMS 1 and hPMS 2 in Predisposing to Colorectal Cancer 1 (2001) (6)
Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
Colonoscopy findings in high-risk individuals compared to an average-risk control population (2015) (6)
Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas. (2004) (6)
Discovery of common and rare genetic risk variants for colorectal cancer (2018) (6)
Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
Whole-genome Linkage Analysis and Sequence Analysis of Candidate Loci in Familial Breast Cancer. (2015) (5)
Correction: Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database (2020) (5)
Report of the Combined Meeting of the International Society for Gastrointestinal Hereditary Tumours, the Human Variome Project and the National Cancer Institute Colon Cancer Family Registry, Duesseldorf, Germany, 24 June 2009 (2010) (5)
Cancer occurrence during follow-up of the CAPP2 study -aspirin use for up to four years significantly reduces Lynch syndrome cancers for up to several years after completion of therapy (2010) (5)
Enhanced detection of mutations in BRCA1 exon 11 using restriction endonuclease fingerprinting-single-strand conformation polymorphism (2000) (5)
Screening for germline phosphatase and tensin homolog-mutations in suspected Cowden syndrome and Cowden syndrome-like families among uterine cancer patients (2015) (5)
Genetic analyses supporting colorectal, gastric, and prostate cancer syndromes (2019) (4)
Autoimmune Markers in Lymphoid Malignancies (2008) (4)
Immunohistochemical Loss of the DNA Mismatch Repair Proteins MSH2 and MSH6 in Malignant Fibrous Histiocytomas (2004) (4)
Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study (2014) (4)
Two novel colorectal cancer risk loci in the region on chromosome 9q22.32 (2018) (4)
Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (2014) (4)
Screening families with endometrial and colorectal cancers for germline mutations (2001) (4)
Sequence variability of a prolonged tetranucleotide repeat. (1995) (4)
Linkage analysis revealed risk loci on 6p21 and 18p11.2-q11.2 in familial colon and rectal cancer, respectively (2019) (4)
Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH 2 B 3 and TSHZ 1 (2015) (4)
Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
Corrigendum: ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma (2008) (4)
Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
Making the environment count : - Nordic accounts and indicators for analysing and integrating environment and economy (2016) (3)
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation (2017) (3)
Testing strategies to reduce morbidity and mortality from Lynch syndrome (2018) (3)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk (2020) (3)
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer (2016) (3)
A region close to Tp53 shows LOH in familial breast cancer. (2002) (3)
Mapping of a new MAP kinase activated protein kinase gene (3PK) to human chromosome band 3p21.2 and ordering of 3PK and two cosmid markers in the 3p22–p21 tumour-suppressor region by two-colour fluorescencein situ hybridization (1996) (3)
TGFBR 1 variants TGFBR 1 * 6 A and Int 7 G 24 A are not associated with an increased familial colorectal cancer risk (2010) (3)
Loss of Heterozygosity in Familial Breast Carcinomas 1 (2006) (2)
Response to Li and Hopper. (2021) (2)
Fine-mapping identi fi es two additional breast cancer susceptibility loci at 9 q 31 . 2 (2015) (2)
Massive parallel sequencing in a family with rectal cancer (2021) (2)
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis (2020) (2)
Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
Hereditary cancer. (1999) (2)
[Essential to discover hereditary colorectal and endometrial cancer. Mutations in "HNPCC individuals" can cause several different tumors]. (2002) (2)
Physical activity and risks of breast and colorectal cancer: A Mendelian randomization analysis (2019) (2)
PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (2)
Loss of heterozygosity studies in tumors from families with breast-ovarian cancer syndrome (1994) (2)
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study (2022) (2)
Prediction and clinical utility of a contralateral breast cancer risk model (2019) (1)
Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report (2017) (1)
Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (2019) (1)
Haplotype analysis suggest that the MLH1 c.2059C > T mutation is a Swedish founder mutation (2017) (1)
Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
TO JMG High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA 1 / BRCA 2 breast cancer (2005) (1)
A search for modifying genetic factors in CHEK2:c.1100delC breast cancer patients (2021) (1)
Identification of known and novel familial cancer genes in Swedish colorectal cancer families (2021) (1)
Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer (2018) (1)
Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (2019) (1)
Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis (2020) (1)
Unravelling genetic variants of a swedish family with high risk of prostate cancer (2022) (1)
The use of intragenic polymorphisms in determination of the genomic relevance of whole‐exon deletions in MLH1 and MSH2 (2001) (1)
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? (2021) (1)
Aalborg Universitet Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by overdiagnosis ; A prospective Lynch syndrome database report (2019) (1)
Syddansk Universitet Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12 p 11 locus (2016) (1)
Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (1)
Identification of nine new susceptibility loci for endometrial cancer (2018) (1)
Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2 (2012) (1)
Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (1)
Colorectal cancer risk susceptibility loci in a Swedish population (2021) (1)
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
A Swedish Genome-Wide Haplotype Association Analysis Identifies a Novel Breast Cancer Susceptibility Locus in 8p21.2 and Characterizes Three Loci on Chromosomes 10, 11 and 16 (2022) (1)
Exome sequencing in a Swedish family with PMS2 mutation with varying penetrance of colorectal cancer: investigating the presence of genetic risk modifiers in colorectal cancer risk (2022) (1)
Salicylic Acid and Risk of Colorectal Cancer: A Two-Sample Mendelian Randomization Study (2021) (1)
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report (2019) (1)
TP 53-based interaction analysis identifies cis-eQTL variants for TP 53 BP 2 , FBXO 28 , and FAM 53 A that associate with survival and treatment outcome in breast cancer (2017) (1)
Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
Body mass index and breast cancer survival (2017) (0)
The use of telephone in genetic counseling versus in-person counseling: a randomized study on counselees’ outcome (2012) (0)
The estrogen receptor alpha C975G variant in familial and sporadic breast cancer: a case-control study. (2006) (0)
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
Prevalence of adenomas and hyperplastic polyps in carriers of HNPCC (LYNCH Syndrome). (2004) (0)
[The first breast cancer gene isolated. Safer risk assessment for affected families]. (1995) (0)
Linkage and association analysis define novel regions for the risk of adenomas and colorectal cancer (2022) (0)
Mutation screening of the SMARCA 3 gene in Swedish colorectal cancer patients (0)
Patient survival and tumor characteristics associated with CHEK2:p.I157T – findings from the Breast Cancer Association Consortium (2016) (0)
Abstract 2205: A potential colorectal cancer susceptibility locus on chromosome 3q (2010) (0)
Familial cancer among consecutive uterine cancer patients in Sweden (2014) (0)
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
Title COGENT ( COlorectal cancer GENeTics ) : An international consortium to study the role of polymorphic variation on the risk of colorectal cancer (2009) (0)
AD51B in Familial Breast Cancer (2016) (0)
Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients (2020) (0)
Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
Association of rs12662670 with breast cancer in Asian ER (2012) (0)
Genome-wide scan of the effect of common nsSNPs on colorectal cancer survival outcome (2018) (0)
Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2017) (0)
Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2018) (0)
Responses - environmental economic instruments (2016) (0)
Polymorphisms in the cyp19 (aromatase) gene with putative role in the regulation of gene expression (1997) (0)
Sequencing for germline mutations in Swedish breast cancer families reveals novel breast cancer risk genes (2021) (0)
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
Edinburgh Research Explorer The MLH1 c.1852_1853delinsGC (p.K618A) Variant in Colorectal Cancer (2018) (0)
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival (2023) (0)
q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
A retrospective study of extracolonic, non-endometrial cancer in Swedish Lynch syndrome families (2018) (0)
Microsatellite instability tumors and chromosomal instability tumors (0)
Specificity Transcription Factor Selectively Alter Its DNA-binding Tumor-associated Zinc Finger Mutations in the CTCF Updated Version (2001) (0)
Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
Mendelian randomization study of age at menarche and age at 1 menopause and the risk of colorectal cancer (2018) (0)
335 Identification of individuals with a genetic predisposition for colon cancer—HNPCC (1995) (0)
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patients (2022) (0)
TITLE: Mendelian randomization of circulating polyunsaturated fatty acids and colorectal cancer risk (2020) (0)
Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality (2019) (0)
Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
The long term impact of resistant starch on cancer risk in carriers of hereditary colorectal cancer:the CAPP2 Randomised Controlled Trial (2012) (0)
Defective DNA mismatch repair as a cause of colon cancer (1994) (0)
Edinburgh Research Explorer TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2018) (0)
Driving forces - from the economy and society (2016) (0)
sense Variants in ATM in 26 , 101 Breast Cancer B & P es and 29 , 842 Controls (2010) (0)
Breast cancer syndromes. A hypothesisgeneration search for new genetic breast cancer syndromes - a national study in 803 Swedish families. (2007) (0)
[Nobody will be punished for one's own hereditary disposition. Genetic information should be protected by law]. (1996) (0)
the Breast Cancer Association Consortium Five Polymorphisms and Breast Cancer Risk : Results from Updated (2009) (0)
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (0)
Cancer in Predisposing to Colorectal hPMS 2 and hPMS 1 The Role of Updated Version (2001) (0)
Erratum: COGENT (COlorectal cancer GENeTics): An international consortium to study the role of polymorphic variation on the risk of colorectal cancer (British Journal of Cancer 102 (447-454) DOI: 10.1038/sj.bjc.6605338)) (2010) (0)
The Nordic countries - an overview (2016) (0)
Pressures on the environment (2016) (0)
Discussions and conclusions (2016) (0)
Exome sequencing in one family with gastric- and rectal cancer (2016) (0)
Increased risk for uterine cancer among first-degree relatives to Swedish gastric cancer patients (2020) (0)
The genetics of breast cancer predisposition. (2006) (0)
' s report Title : Activating mutation in MET oncogene is inherited in familial colorectal cancer cases Version : 1 Date : 27 July 2011 (0)
Correction to: Genetic variant predictors of gene expression provide new insight into risk of colorectal cancer (2019) (0)
Shared heritability and functional enrichment across six solid cancers (2019) (0)
Unravelling genetic variants of a swedish family with high risk of prostate cancer (2022) (0)
Selected Abstracts from the 3rd European Hereditary Tumour Group Meeting (EHTG 2018) (2019) (0)
Linkage Analysis withMarkers on 17qin29SwedishBreast CancerFamilies (1993) (0)
Localization and ordering of the human 3PK gene and five other human chromosome 3 markers. Attempt to establish the borders of the nonrandomly eliminated putative chromosome 3 tumor suppressor regions in mouse-human microcell hybrid derived SCID tumors (1996) (0)
Psychological reactions among women with high risk of breast cancer considering prophylactic mastectomy (2001) (0)
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer (0)
Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries (2023) (0)
Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
Importance to Clarify Germline Hmlh1 K618A Missense Mutation for Clinical Surveillance and Genetic Counseling (2014) (0)
Mortality by age, gene and gender in carriers of pathogenic mismatch repair gene variants receiving surveillance for early cancer diagnosis and treatment: a report from the prospective Lynch syndrome database (2023) (0)
[Families with hereditary cancer--a target group for prevention]. (1990) (0)
Validation of a genetic-enhanced risk prediction model for colorectal cancer in a large community-based cohort. (2023) (0)
Importance to clarify germline hMLH1 K618A missense mutation for clinical surveillance and genetic counseling. (2018) (0)
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer (2010) (0)
Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report (2019) (0)
Foreword by the chair of the Ad Hoc group (2016) (0)
Linkage analysis revealed risk loci on 6p21 and 18p11.2-q11.2 in familial colon and rectal cancer, respectively (2019) (0)
On Precision in Estimates of Change over Time where Samples are Positively Coordinated by Permanent Random Numbers (2014) (0)
Cumulative impact of 10 common genetic variants on colorectal cancer risk in 42,333 individuals from eight populations (2013) (0)
Mutation screening of the SMARCA3 gene in Swedish colorectal cancer patients. (2008) (0)
Altered class switch recombination junctions in patients with deficiency in Mlh1 and Brca1 (109.6) (2012) (0)
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) (0)
Parent of Origin and Prognosis in Familial Breast Cancer in Sweden. (2017) (0)
Abstract 2685: Identification of circulating protein biomarkers for colorectal cancer risk: A genetic instrument analysis (2019) (0)
Predisposition forBreast CancerinCarriers ofConstitutional Translocation IIq;22q (1994) (0)
On-going initiatives and processes (2016) (0)
TGFßRII mutations in sporadic epithelial tumors with unstable Phenotype (1995) (0)
SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. (2012) (0)
a novel candidate breast cancer susceptibility locus on (2017) (0)
MSI Test to Distinguish between HNPCC and Other Predisposing Syndromes – of Value in Tailored Surveillance (2004) (0)
Colorectal cancer incidence in path _ MLH 1 carriers subjected to different follow-up protocols (2017) (0)
Massive parallel sequencing in a family with rectal cancer (2021) (0)
Cancer Risks for PMS2-Associated Lynch Syndrome (vol 29, pg 2961, 2018) (2019) (0)
Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden (2015) (0)
Extensions and analysis - options for data and policy use (2016) (0)
A Swedish Familial Genome-Wide Haplotype Analysis Identified Five Novel Breast Cancer Susceptibility Loci on 9p24.3, 11q22.3, 15q11.2, 16q24.1 and Xq21.31 (2023) (0)
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
Explorer COGENT ( COlorectal cancer GENeTics ) : an international consortium to study the role of polymorphic variation on the risk of colorectal cancer (2017) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Annika A. Lindblom?

Annika A. Lindblom is affiliated with the following schools: